The Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Completed the Phase I Clinical Trial of Neurostem®-AD

This study is currently recruiting participants.
Verified September 2012 by Samsung Medical Center
Sponsor:
Collaborator:
Medipost Co Ltd.
Information provided by (Responsible Party):
Duk Lyul Na, Samsung Medical Center
ClinicalTrials.gov Identifier:
NCT01696591
First received: September 7, 2012
Last updated: September 27, 2012
Last verified: September 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2013
  Estimated Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)